Sign in
Author
|
Conference
|
Journal
|
Organization
|
Year
|
DOI
Look for results that meet for the following criteria:
since
equal to
before
between
and
Search in all fields of study
Limit my searches in the following fields of study
Agriculture Science
Arts & Humanities
Biology
Chemistry
Computer Science
Economics & Business
Engineering
Environmental Sciences
Geosciences
Material Science
Mathematics
Medicine
Physics
Social Science
Multidisciplinary
Keywords
(8)
Adjuvant Therapy
Complementary Therapies
Hormone Therapy
Prognostic Factor
Side Effect
Breast Cancer
Sentinel Lymph Node
Therapeutic Index
Subscribe
Academic
Publications
AGO Recommendations for the Diagnosis and Therapy of Breast Cancer
AGO Recommendations for the Diagnosis and Therapy of Breast Cancer,10.1159/000107073,Breast Care,Christoph Thomssen,Ingo Bauerfeind,Joachim Bischoff,J
Edit
AGO Recommendations for the Diagnosis and Therapy of Breast Cancer
BibTex
|
RIS
|
RefWorks
Download
Christoph Thomssen
,
Ingo Bauerfeind
,
Joachim Bischoff
,
Jens Uwe Blohmer
,
Klaus Brunnert
,
Serban D. Costa
,
Peter Dall
,
Ingo J. Diel
,
Nikos Fersis
,
Michael Friedrich
,
Kay Friedrichs
,
Bernd Gerber
http://academic.research.microsoft.com/io.ashx?type=5&id=31977059&selfId1=0&selfId2=0&maxNumber=12&query=
In January 2007, the �AGO Kommission Mamma� for the 5th time updated the �AGO Recommendations for the Diagnostic and Therapy of Breast Cancer� that were established and published for the first time in 2002. The most important statements and modifications are described here. With regard to adjuvant therapy, the definition of the recommended regimens could be established more precisely. The increasing knowledge about the clinical value of
sentinel lymph node
excision is taken into consideration. For the pathological work-up, the needs and standards of additional markers and prognostic factors were better defined and adjusted to the guidelines of the German pathologists. The routine use of gene arrays for therapy decision is still rejected. Detailed recommendations were established for acute and long-term side effects of therapy. In the chapter �specific situations�, CUP (carcinoma of unknown primary) syndrome and phyllodes tumor were included. Taking into account the improved prognosis of breast cancer, specific advice for survivors and information about complementary therapy, hormone therapies, and contraception was prepared in detail. The treatment principles of metastastic disease have not changed substantially, thus pronouncing the significance of guiding therapy by defining the goal and estimating the
therapeutic index
for each situation.
Journal:
Breast Care
, vol. 2, no. 4, pp. 244-250, 2007
DOI:
10.1159/000107073
Cumulative
Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.
(
www.online.karger.com
)
(
www.karger.com
)